EVOK - Evoke Pharma, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
0
0
0
0
0
Cost of Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
0
Operating Expenses
Research Development
3,273
4,095
7,137
6,952
8,154
Selling General and Administrative
4,111
3,920
4,093
3,593
3,664
Total Operating Expenses
7,385
8,015
11,231
10,544
11,818
Operating Income or Loss
-7,385
-8,015
-11,231
-10,544
-11,818
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
-
433
-1,005
598
-303
Income Before Tax
-7,359
-7,566
-12,230
-10,749
-12,121
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-7,359
-7,566
-12,230
-10,749
-12,121
Net Income
-7,359
-7,566
-12,230
-10,749
-12,121
Net Income available to common shareholders
-7,359
-7,566
-12,230
-10,749
-12,121
Reported EPS
Basic
-
-0.46
-0.82
-1.15
-1.87
Diluted
-
-0.46
-0.90
-1.15
-1.87
Weighted average shares outstanding
Basic
-
16,602
14,898
9,338
6,486
Diluted
-
16,602
14,951
9,338
6,486
EBITDA
-
-8,015
-11,231
-10,544
-11,818